Joung JG - Search Results

1

Pan-Cancer Analysis of Alternative Lengthening of Telomere Activity.

Sung JY, Lim HW, Joung JG, Park WY. Sung JY, et al. Among authors: joung jg. Cancers (Basel). 2020 Aug 7;12(8):2207. doi: 10.3390/cancers12082207. Cancers (Basel). 2020. PMID: 32784588 Free PMC article.

2

Assessment of intratumoral heterogeneity with mutations and gene expression profiles.

Sung JY, Shin HT, Sohn KA, Shin SY, Park WY, Joung JG. Sung JY, et al. Among authors: joung jg. PLoS One. 2019 Jul 16;14(7):e0219682. doi: 10.1371/journal.pone.0219682. eCollection 2019. PLoS One. 2019. PMID: 31310640 Free PMC article.

3

Integrative Radiogenomics Approach for Risk Assessment of Post-Operative Metastasis in Pathological T1 Renal Cell Carcinoma: A Pilot Retrospective Cohort Study.

Lee HW, Cho HH, Joung JG, Jeon HG, Jeong BC, Jeon SS, Lee HM, Nam DH, Park WY, Kim CK, Seo SI, Park H. Lee HW, et al. Among authors: joung jg. Cancers (Basel). 2020 Apr 2;12(4):866. doi: 10.3390/cancers12040866. Cancers (Basel). 2020. PMID: 32252440 Free PMC article.

4

Deciphering intratumor heterogeneity using cancer genome analysis.

Ryu D, Joung JG, Kim NK, Kim KT, Park WY. Ryu D, et al. Among authors: joung jg. Hum Genet. 2016 Jun;135(6):635-42. doi: 10.1007/s00439-016-1670-x. Epub 2016 Apr 28. Hum Genet. 2016. PMID: 27126234 Review.

5

Biomarkers Associated with Tumor Heterogeneity in Prostate Cancer.

Yun JW, Lee S, Ryu D, Park S, Park WY, Joung JG, Jeong J. Yun JW, et al. Among authors: joung jg. Transl Oncol. 2019 Jan;12(1):43-48. doi: 10.1016/j.tranon.2018.09.003. Epub 2018 Sep 25. Transl Oncol. 2019. PMID: 30265975 Free PMC article.

6

Renal Cell Carcinoma-Infiltrating CD3^low Vγ9Vδ1 T Cells Represent Potentially Novel Anti-Tumor Immune Players.

Lee HW, Park C, Joung JG, Kang M, Chung YS, Oh WJ, Yeom SY, Park WY, Kim TJ, Seo SI. Lee HW, et al. Among authors: joung jg. Curr Issues Mol Biol. 2021 May 27;43(1):226-239. doi: 10.3390/cimb43010019. Curr Issues Mol Biol. 2021. PMID: 34071865 Free PMC article.

7

Earlier-Phased Cancer Immunity Cycle Strongly Influences Cancer Immunity in Operable Never-Smoker Lung Adenocarcinoma.

Kim HK, Joung JG, Choi YL, Lee SH, Park BJ, Choi YS, Ryu D, Nam JY, Lee MS, Park WY, Hwang S, Cha H, Kim HS, Lee S, Jung Y, Lee JE, Doh J, Paik S, Kang JH, Lee J, Kim J. Kim HK, et al. Among authors: joung jg. iScience. 2020 Aug 21;23(8):101386. doi: 10.1016/j.isci.2020.101386. Epub 2020 Jul 18. iScience. 2020. PMID: 32795913 Free PMC article.

8

The role of PDGFRA as a therapeutic target in young colorectal cancer patients.

Kim TW, Hong HK, Lee C, Kim S, Lee WY, Yun SH, Kim HC, Huh JW, Park YA, Joung JG, Park WY, Cho YB. Kim TW, et al. Among authors: joung jg. J Transl Med. 2021 Oct 26;19(1):446. doi: 10.1186/s12967-021-03088-7. J Transl Med. 2021. PMID: 34702313 Free PMC article.

9

Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation.

Kim N, Cho A, Watanabe H, Choi YL, Aziz M, Kassner M, Joung JG, Park AK, Francis JM, Bae JS, Ahn SM, Kim KM, Park JO, Park WY, Ahn MJ, Park K, Koo J, Yin HH, Cho J. Kim N, et al. Among authors: joung jg. Oncotarget. 2016 Mar 22;7(12):13797-809. doi: 10.18632/oncotarget.7318. Oncotarget. 2016. PMID: 26883194 Free PMC article.

10

Predicting multi-class responses to preoperative chemoradiotherapy in rectal cancer patients.

Gim J, Cho YB, Hong HK, Kim HC, Yun SH, Wu HG, Jeong SY, Joung JG, Park T, Park WY, Lee WY. Gim J, et al. Among authors: joung jg. Radiat Oncol. 2016 Mar 22;11:50. doi: 10.1186/s13014-016-0623-9. Radiat Oncol. 2016. PMID: 27005571 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page